EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cellular Heterogeneity of Activated Primary Human Macrophages and Associated Drug–Gene Networks: From Biology to Precision Therapeutics

Julius L Decano iD, Enrico Maiorino iD, Joan T Matamalas iD, Sarvesh Chelvanambi iD, Bart M Tiemeijer iD, Yoshihiro Yanagihara iD, Shin Mukai iD, Prabhash Kumar Jha, Diego V S Pestana iD, Edwin D'Souza iD, Mary Whelan iD, Rile Ge iD und 6 weitere

Circulation · 2023

DOI: 10.1161/circulationaha.123.064794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2023. Verfasst von Julius L Decano und 17 weiteren Autor:innen. Beteiligte Einrichtung: Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division (J.L.D., J.T.M., S.C., B.M.T., Y.Y., S.M., D.V.S.P., E.D., M.W., R.G., …. Hauptthemen laut MEDLINE: Atherosclerosis, Plaque, Atherosclerotic. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Interferon-γ (IFNγ) signaling plays a complex role in atherogenesis. IFNγ stimulation of macrophages permits in vitro exploration of proinflammatory mechanisms and the development of novel immune therapies. We hypothesized that the study of macrophage subpopulations could lead to anti-inflammatory interventions. METHODS: Primary human macrophages activated by IFNγ (M(IFNγ)) underwent analyses by single-cell RNA sequencing, time-course cell-cluster proteomics, metabolite consumption, immunoassays, and functional tests (phagocytic, efferocytotic, and chemotactic). RNA-sequencing data were analyzed in LINCS (Library of Integrated Network-Based Cellular Signatures) to identify compounds targeting M(IFNγ) subpopulations. The effect of compound BI-2536 was tested in human macrophages in vitro and in a murine model of atherosclerosis. RESULTS: Single-cell RNA sequencing identified 2 major clusters in M(IFNγ): inflammatory (M(IFNγ) i ) and phagocytic (M(IFNγ) p ). M(IFNγ) i had elevated expression of inflammatory chemokines and higher amino acid consumption compared with M(IFNγ) p . M(IFNγ) p were more phagocytotic and chemotactic with higher Krebs cycle activity and less glycolysis than M(IFNγ) i . Human carotid atherosclerotic plaques contained 2 such macrophage clusters. Bioinformatic LINCS analysis using our RNA-sequencing data identified BI-2536 as a potential compound to decrease the M(IFNγ) i subpopulation. BI-2536 in vitro decreased inflammatory chemokine expression and secretion in M(IFNγ) by shrinking the M(IFNγ) i subpopulation while expanding the M(IFNγ) p subpopulation. BI-2536 in vivo shifted the phenotype of macrophages, modulated inflammation, and decreased atherosclerosis and calcification. CONCLUSIONS: We characterized 2 clusters of macrophages in atherosclerosis and combined our cellular data with a cell-signature drug library to identify a novel compound that targets a subset of macrophages in atherosclerosis. Our approach is a precision medicine strategy to identify new drugs that target atherosclerosis and other inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisPlaque, AtheroscleroticHumansAnimalsMiceGene Regulatory NetworksMacrophagesRNABiology

Stichwörter der Autor:innen

atherosclerosisinflammationmacrophagesmultiomicsphagocytosissystems biology

Substanzen

RNA

Autor:innen und Institutionen

  • Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division (J.L.D., J.T.M., S.C., B.M.T., Y.Y., S.M., D.V.S.P., E.D., M.W., R.G., T.A., A.S., S.A.S., E.A., M.A.), Brigham and Women's Hospital, Harvard…
  • Channing Division of Network Medicine (E.M., A.S., M.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Department of Medicine, and Center for Excellence in Vascular Biology (P.K.J., P.L., E.A., M.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

ORCID-Profile: Julius L Decano, Enrico Maiorino, Joan T Matamalas, Sarvesh Chelvanambi, Bart M Tiemeijer, Yoshihiro Yanagihara, Shin Mukai, Diego V S Pestana, Edwin D'Souza, Mary Whelan, Rile Ge, Peter Libby, Sasha A Singh, Elena Aikawa, Masanori Aikawa

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Decano, J. L., Maiorino, E., Matamalas, J. T., Chelvanambi, S., Tiemeijer, B. M., Yanagihara, Y., Mukai, S., Jha, P. K., Pestana, D. V. S., D'Souza, E., Whelan, M., Ge, R., Asano, T., Sharma, A., Libby, P., Singh, S. A., Aikawa, E., & Aikawa, M. (2023). Cellular Heterogeneity of Activated Primary Human Macrophages and Associated Drug–Gene Networks: From Biology to Precision Therapeutics. Circulation. https://doi.org/10.1161/circulationaha.123.064794

Vancouver

Decano JL, Maiorino E, Matamalas JT, Chelvanambi S, Tiemeijer BM, Yanagihara Y, et al. Cellular Heterogeneity of Activated Primary Human Macrophages and Associated Drug–Gene Networks: From Biology to Precision Therapeutics. Circulation. 2023. doi:10.1161/circulationaha.123.064794

BibTeX
@article{Decano2023,
  author = {Decano, Julius L and Maiorino, Enrico and Matamalas, Joan T and Chelvanambi, Sarvesh and Tiemeijer, Bart M and Yanagihara, Yoshihiro and Mukai, Shin and Jha, Prabhash Kumar and Pestana, Diego V S and D'Souza, Edwin and Whelan, Mary and Ge, Rile and Asano, Takaharu and Sharma, Amitabh and Libby, Peter and Singh, Sasha A and Aikawa, Elena and Aikawa, Masanori},
  title = {Cellular Heterogeneity of Activated Primary Human Macrophages and Associated Drug–Gene Networks: From Biology to Precision Therapeutics},
  journal = {Circulation},
  year = {2023},
  doi = {10.1161/circulationaha.123.064794}
}
Kostenlos starten →